,for, Item ID-
  • #888108
  • Ortho Clinical Diagnostics #Z488

Immunoassay Reagent Fetalscreen™ II Red Blood Cells For detection and identification of variety of Blood Group Antibodies

FETALSCREEN II RGT 4X5ML D/S

No Image

Features

  • A test for detection of D (RHo) positive fetal red blood cells in maternal circulation to aid in screening and prevention of hemolytic disease of the newborn (HDN)
  • The test is an important screening component for the detection, prevention, and management of Hemolytic Disease of the Newborn
  • The test uses an innovative blend of monoclonal antibodies for stability and accuracy, enzyme-treated indicator cells to facilitate robust reactivity and results clarity, and fewer microscopic fields to simplify results reading and interpretation
  • More …
  Log In to Order
or

Product Specifications


Features
  • A test for detection of D (RHo) positive fetal red blood cells in maternal circulation to aid in screening and prevention of hemolytic disease of the newborn (HDN)
  • The test is an important screening component for the detection, prevention, and management of Hemolytic Disease of the Newborn
  • The test uses an innovative blend of monoclonal antibodies for stability and accuracy, enzyme-treated indicator cells to facilitate robust reactivity and results clarity, and fewer microscopic fields to simplify results reading and interpretation
  • The test can be performed in both hospitals and blood banks
  • HIGH Complexity designation – All test systems, assays or examinations used in compatibility testing when performed to determine donor/recipient compatibility: recipient & donor ABO group/D (Rho) type/antigen typing, direct antiglobulin test, tests for unexpected antibody detection & identification, & crossmatch procedures are HIGH Complexity. See: Federal Register notice, February 28, 1992 [57 FR 7245]

Professionals Also Viewed